media
This media page with its press kit of terraplasma provides up-to-date news, insights, and media resources about our pioneering work in cold plasma technology. Here, journalists, partners, and interested readers can find press releases, expert statements, and background information on our latest innovations in air purification, water treatment, disinfection, and more.
We are committed to transparent communication and are happy to support media inquiries with expert interviews and detailed materials. For press requests or collaboration opportunities, please feel free to contact us. Stay informed about how terraplasma is shaping the future of plasma technology!
terraplasma GmbH
Parkring 32
D-85748 Garching, Germany
press releases
terraplasma focuses on innovative water treatment with patented cold plasma technology
Garching / Munich, March 21st, 2025 – Tomorrow is World Water Day: The aim of this day of action, launched by UNESCO in 1993, is to draw attention to the importance of (clean) water as the most important basis of life for all of hu-manity. Water is a limited and increasingly scarce resource. Around 785 mil-lion people are already affected by acute water shortages. The availability and quality of water is currently changing dramatically due to population growth and climate change and is constantly becoming the greatest challenge for us humans. These are good reasons for terraplasma GmbH to focus more on the large field of water treatment and to continue its success story.
terraplasma is developing a demonstrator for water treatment with Cold Plasma on an industrial scale
A few months ago, the Cold Plasma pioneers at terraplasma GmbH were able to show that with their highly effective technology it is possible to reduce the so-called “forever chemicals” (PFAS Per- and polyFluorinated Alkyl Substances) in drinking water. As part of a research study funded by ESA Spark Funding (https://www.esa-technology-broker.it/spark-funding/), the company wants to expand its research and develop a water treatment system with a significantly more powerful flow rate. Under the project name “Plasma Pure Water”, ter-raplasma aims to complete a larger demonstration system that will meet the requirements of large households and smaller industrial applications with at least 100 liters per minute. A first prototype named “tpWater” is already being tested and optimized.
Impressions from BayOConnect 2024 in Munich
“replacing chemicals. the sustainable way.” Under this motto, the innovation leader from Garching near Munich promotes the many different possible uses of cold plasma technology in the areas of biotech and life science. Cold plasma is perfect for replacing conventional disinfection solutions with chemicals, UV, heat or radiation, for example, and thus enables true sustainability. An excellently suitable platform is the BayOConnect 2024 event, in which terraplasma actively participated as speaker and exhibitor.
Aerosol-assisted cold plasma technology from terraplasma for disinfecting surfaces reaches important milestone
Cold atmospheric plasma (cold plasma for short) is already proving its effectiveness in the treatment of chronic and acute wounds by reducing microorganisms without contact or chemicals. Viruses, fungi and bacteria, including multi-resistant pathogens (MRE), are efficiently and sustainably destroyed by cold plasma. It therefore made sense to extend this active principle to other areas of application, such as the disinfection of objects and surfaces. With a prototype called “tpTop”, a handy and mobile cold plasma decontamination device with aerosol support, it has now been possible to deactivate up to 99.9% of microorganisms within a few seconds of treatment. This opens up new application possibilities for the future, such as the fast and sustainable disinfection of surfaces of all kinds.
Cold plasma, biotech and life science: terraplasma shows sustainable innovations in Munich
“replacing chemicals. the sustainable way.” Under this motto, the innovation leader from Garching near Munich promotes the many different possible uses of cold plasma technology in the areas of biotech and life science. Cold plasma is perfect for replacing conventional disinfection solutions with chemicals, UV, heat or radiation, for example, and thus enables true sustainability. An excellently suitable platform is the BayOConnect event, in which terraplasma actively participates as an exhibitor.
Effective against PFAS: terraplasma successfully tests its own cold plasma technology for water treatment
Successful initial attempts to treat drinking water contaminated with PFAS: this is how terraplasma, the innovation leader in the area of development and implementation of applications with cold atmospheric plasma (in short: cold plasma or cold plasma), succeeded with its self-developed energy-saving cold plasma technology for water treatment alongside other substances such as For example, microorganisms and PFAS can be significantly reduced in a measurable way. In a first, larger series of tests with real water samples from a southern Bavarian PFAS hotspot, some of the so-called “forever chemicals” were reduced by up to almost 30%. Reason enough for the company to further optimize its technology and, together with potential partners, develop it into a ready-made solution for water treatment.
about terraplasma
terraplasma GmbH is a female-founded deep-tech startup, created as a spin-off of the Max-Planck Society in 2011, and is a leader and pioneer in the research, development and application of cold atmospheric plasma (CAP).
The company based in Garching near Munich, offers innovative cold plasma solutions and technologies in areas where bacteria, fungi, viruses, spores, allergens and odor molecules must be permanently inactivated. Cold plasmas are partially ionized gases that, thanks to their high effectiveness, can replace conventional chemicals or other technologies such as UV, heat or radiation in an increasing number of applications.
With its proven technologies, the cold plasma pioneers at terraplasma work with well-known companies in the areas of medical technology, hygiene, water treatment, odor management, air purification, cosmetics, surface modification and many more.
It is terraplasma’s goal to further develop and market its environmentally friendly cold plasma solutions in line with needs together with these partners from the industry. A young team that works with a lot of creativity and sophistication, extensive know-how in the areas of cold plasma research and technology as well as over 60 patents worldwide support the company on its path to success.
(profile 191 words / 1280 letters including spaces)
management
Dr. Julia Zimmermann
Dr. Julia Zimmermann is co-founder and Managing Director of terraplasma GmbH since 2015, as well as past CEO of terraplasma’s daughter company terraplasma medical GmbH, with a strategic exit in 2023. Prior to founding terraplasma GmbH, she worked at the Max-Planck-Institute for Extraterrestrial Physics and completed her PhD in biophysics at the LMU (Ludwig Maximilians University in Munich). Furthermore, Julia founded a new daughter company named hyped about science GmbH in early 2025 which she also runs as Managing Director.
(89 words / 517 letters including spaces)
Rico Unger
Rico Unger, Managing Director, has been heading technological innovation at terraplasma since May 2021. With a strong entrepreneurial spirit, he previously led research and development departments and co-founded Dynamify GmbH, showcasing his expertise in advanced engineering solutions. Based in Munich, Rico brings extensive experience in cutting-edge technology development, particularly in medical device engineering and cold plasma applications.
57 words / 449 letters including spaces
Prof. Dr. Gregor Morfill
Prof. Dr. Gregor Morfill is renowned for his groundbreaking work in astrophysics and plasma physics. After completing his PhD at Imperial College London, Greg held various prestigious positions, including professorships at the Max Planck Institute for Nuclear Physics and Heidelberg University, and served as Director at the Max Planck Institute for Extraterrestrial Physics beginning in 1984. He has authored over 500 scientific publications and received numerous awards, including the James Clerk Maxwell Prize for Plasma Physics in 2011.
(90 words / 540 letters including spaces)
plasma and cold plasma
whitepaper "introduction to cap cold atmospheric plasma"
Plasma, the fourth state of matter, consists of ionized gases with free electrons and charged particles. It exists in two main forms: hot plasma and cold plasma.
Hot plasma, found in stars and fusion reactors, exists at extremely high temperatures (millions of degrees). In this state, all particles (electrons and heavy ions) are in thermal equilibrium, meaning they share the same high energy levels. Hot plasma is fully ionized and plays a crucial role in astrophysics and nuclear fusion research.
Cold plasma, also known as non-thermal plasma, operates at much lower temperatures (often close to room temperature). Here, electrons are highly energetic, but heavier particles (ions and neutrals) remain relatively cool. This makes cold plasma ideal for applications like sterilization, air and water purification, wound healing, and surface treatment. Unlike hot plasma, it can be safely used in biomedical and industrial processes without causing thermal damage.
commercial products with cold plasma
Disinfection with PlasmaEgg®
The PlasmaEgg® by Kimetec GmbH is a groundbreaking innovation in disinfection, made in Germany. Designed for the effective and chemical-free decontamination of everyday objects, laboratory equipment, and personal protective gear, it utilizes cold atmospheric plasma to destroy bacteria, viruses, fungi, and even multi-resistant germs by targeting their proteins and RNA/DNA.
With no risk of resistance, a sustainable approach, and a spacious 1.5-litre chamber, the PlasmaEgg® sets new standards for high-level disinfection in various applications.
Skin care with Phlas®
Introducing Phlas®, the revolutionary cold plasma device from hyped about science GmbH, a Munich-based skin-tech company. Phlas® utilizes advanced ionized gas technology to enhance and protect your skin by strengthening its barrier, reducing redness, and soothing irritation. Gentle and free from heat or harsh chemicals, Phlas is safe for all skin types.
Developed by serial entrepreneur Dr. Julia Zimmermann, a world-renowned expert in cold plasma devices, Phlas® brings medical-grade skincare technology, originally designed for treating wounds and skin diseases, into your daily routine. Born from groundbreaking experiments aboard the International Space Station, Phlas® sets new standards in beauty innovation, making science work for you.
Wound healing with plasma care®
The plasma care® by terraplasma medical GmbH is a handy and mobile medical device for wound treatment using cold atmospheric plasma. It is approximately the size and weight of a telephone receiver and has a battery capacity that is sufficient for about 120 treatments. It can therefore be used by outpatient wound specialists, but also in clinical and office-based settings.
To guarantee sterile treatment and avoid cross-contamination, the plasma care® is used in combination with a sterile-packed spacer. The following rule applies: One spacer per patient and wound. The treatment area per wound area is 13 cm². For larger wounds, the spacer can be used up to 6 times within one treatment session (total area about 73 cm²). Afterwards, the spacer is invalid and must be disposed off.
Odor management with FreshUp®
Introducing FreshUp® by Bosch, an innovative device that refreshes your clothes and dry textiles by eliminating unpleasant odors without the use of water or chemicals. Utilizing advanced terraplasma’s cold plasma technology, FreshUp® breaks down odor molecules, leaving your garments smelling fresh and clean.
Its compact and portable design allows for on-the-go use, making it convenient to refresh your attire anytime, anywhere. Say goodbye to unwanted smells and enjoy the confidence of freshly revitalized clothing with Bosch FreshUp®.
partners
publications
Here you will find all of our scientific publications sorted by year.
Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in-vitro study
T. F. Brunner, F. A. Probst, M. Troeltzsch, S. Schwenk-Zieger, J. L. Zimmermann, G. Morfill, S. Becker, U. Harréus and C. Welz
Head Face Med, 2022 (18) 21 (2022), DOI: 10.1186/s13005-022-00322-5
Plasma Care®
J. L. Zimmermann, C. C. Roskopf, S. Cantzler, J. Kirsch, R. Unger, H. Weilemann, M. Cantzler, M. Linner, M. Wunderl and T. Maisch (eds) Metelmann, HR., von Woedtke, T., Weltmann, KD., Emmert, S.
In: Textbook of Good Clinical Practice in Cold Plasma Therapy. Springer (2022) DOI: 10.1007/978-3-030-87857-3_19
Cold Atmospheric Plasma Changes the Amino Acid Composition of Solutions and Influences the Anti-Tumor Effect on Melanoma Cells
S. Arndt, F. Fadil, K. Dettmer, P. Unger, M. Boskovic, C. Samol, A.-K. Bosserhoff, J. L. Zimmermann, M. Gruber, W. Gronwald and S. Karrer
International Journal of Molecular Science, 2021, 22(15), 7886, DOI: 10.3390/ijms22157886
Cold Atmospheric Plasma Promotes the Immunoreactivity of Granulocytes In Vitro
L. S. Kupke, S. Arndt, S. Lenzer, S. Metz, P. Unger, J. L. Zimmermann, A.-K. Bosserhoff, M. Gruber and S. Karrer
Biomolecules, 2021, 11(6):902, DOI: 10.3390/biom11060902
The latest time point of retreatment (LTPR) as a novel method to determine antibacterial effects for binary use of cold atmospheric plasma and conventional agents
S. Schramm, K.-A. Hiller, S. Cantzler, H. Weilemann, M. Cantzler, J. L. Zimmermann, F. Cieplik and T. Maisch
Frontiers in Microbiology, DOI: 10.3389/fmicb.2020.576500
The molecular Effects of cold atmospheric Plasma on malignant Melanoma
T. Zimmermann, C. Schneider, L. Gebhardt, S. Arndt, S. Karrer, J. L. Zimmermann, M. J. M. Fischer and A. K. Bosserhoff
Journal Der Deutschen Dermatologischen Gesellschaft, 18
Antibacterial efficacy of cold atmospheric plasma against Enterococcus faecalis planktonic cultures and biofilms in vitro
F. Theinkom, L. Singer, F. Cieplik, S. Cantzler, H. Weilemann, M. Cantzler, K.-A. Hiller, T. Maisch and J. L. Zimmermann
PLOS ONE 14(11): e0223925. https://doi.org/10.1371/journal.pone.0223925 (2019)
Acidification is an Essential Process of Cold Atmospheric Plasma and Promotes the Anti-Cancer Effect on Malignant Melanoma Cells
C. Schneider, L. Gebhardt, S. Arndt, S. Karrer, J. L. Zimmermann, M. J. M. Fischer and A.-K. Bosserhoff
Cancers 2019, 11, 671; doi:10.3390/cancers11050671 (2019)
Effects of cold atmospheric plasma (CAP) on bacteria and mucosa of the upper aerodigestive tract
S. Becker, J. L. Zimmermann, P. Baumeister, T. F. Brunner, T. Shimizu, Y. Li, G. E. Morfill, U. Harréus and C. Welz
Auris Nasus Larynx, Volume 46, Issue 2, April 2019, Pages 294-301 (2019)
Reduktion von Yersinia enterocolitica, ESBL-bildenden Escherichia coli und MRSA durch kaltes Atmosphärendruck Plasma
K. A. Lis, C. Kehrenberg, A. Boulaaba, M. Köckritz-Blickwede, S. Binder, Y. Li, J. L. Zimmermann, Y. Pfeifer and B. Ahlfeld
60. Arbeitstagung des Arbeitsgebietes Lebensmittelsicherheit und Verbraucherschutz: zusammen mit der Sektion Lebensmittel Tierischer Herkunft in der Österreichischen Gesellschaft der Tierärzte und der Schweizerischen Tierärztlichen Vereinigung für Lebensmittelsicherheit und Tiergesundheit. S. 301–303
Plasma afterglow circulation apparatus for decontamination of spacecraft equipment
M. Müller, T. Shimizu, S. Binder, P. Rettberg, J. L. Zimmermann, G. E. Morfill and H. Thomas
AIP Advances 8, 105013 (2018), DOI: 10.1063/1.5040303
Cold atmospheric plasma treatment inhibtis growth in colorectal cancer cells
C. Schneider, S. Arndt, J. L. Zimmermann, Y. Li, S. Karrer and A.-K. Bosserhoff
Biological Chemistry, 400(1), 111-122 (2018)
Cold atmospheric plasma causes a calcium influx in melanoma cells triggering CAP-induced senescence
C. Schneider, L. Gebhardt, S. Arndt, S. Karrer, J. L. Zimmermann, M. J.M. Fischer and A.-K. Bosserhoff
Scientific Reports 8, 10048 (2018)
Inactivation of Salmonella Typhimurium and Listeria monocytogenes on ham with nonthermal atmospheric pressure plasma
K. A. Lis, A. Boulaaba, S. Binder, Y. Li, C. Kehrenberg, J. L. Zimmermann, G. Klein and B. Ahlfeld
PLOS ONE 13, 5, e0197773 (2018)
Inactivation of multidrug-resistant pathogens and Y. enterocolitica with cold atmospheric pressure plasma on stainless steel surfaces
K. A. Lis, A. Boulaaba, M. v. Köckritz-Blickwede, S. Binder, Y. Li, J. L. Zimmermann, Y. Pfeifer, C. Kehrenberg and B. Ahlfeld
International Journal of Antimicrobial Agents, Volume 52, Issue 6, December 2018, Pages 811-818 (2018)
Disinfection of Dental Equipment—Inactivation of Enterococcus mundtii on Stainless Steel and Dental Handpieces using Surface Micro-Discharge Plasma
J. Mandler, S. Moritz, S. Binder, T. Shimizu, M. Müller, M. H. Thoma and J. L. Zimmermann
Plasma Medicine, Volume 7 Issue 7 p. 407-416, DOI: 10.1615/PlasmaMed.2018019502 (2017)
Surface Micro-Discharge Plasma for Disinfection
T. Shimizu, V. Lachner and J. L. Zimmermann
Plasma Medicine, DOI: 10.1615/PlasmaMed.2017019455 (2017)
Investigation of toxicity and mutagenicity of cold atmospheric argon plasma
T. Maisch, A.-K. Bosserhof, P. Unger, J. Heider, T. Shimizu, J. L. Zimmermann, G. Morfill, M. Landthaler and S. Karrer
Environmental and Molecular Mutagenesis (2017)
Plasma Crystals – from Space Research to Medicine on Earth and back to Space again
G. E. Morfill, V. Fortov and J. L. Zimmermann
ROOM, the Space Journal 2 (8) (2016)
Cold atmospheric plasma: a promising complementary therapy for squamous head and neck cancer
C. Welz, S. Emmert, M. Canis, S. Becker, P. Baumeister, T. Shimizu, G. Morfill, U. Harréus and J. L. Zimmermann
PLoS One 10, 11, e0141827 (2015)
Cold atmospheric plasma (CAP) induces ß-defensins in skin keratinocytes in vitro and in vivo without causing relevant inflammation or apoptosis
S. Arndt, M. Landthaler, J. L. Zimmermann, P. Unger, E. Wacker, T. Shimizu, Y.-F. Li, G. E. Morfill, A.-K. Bosserhoff and S. Karrer
PLoS One 10, 3, e0120041 (2015)
Inactivation of a food-borne norovirus outbreak strain with non-thermal atmospheric pressure plasma
B. Ahlfeld, Y. Li, A. Boulaaba, A. Binder, U. Schotte, J. L. Zimmermann, G. Morfill and G. Klein
mBio 6, 1, e02300-14 (2015)
Sporicidal Properties from Surface Micro-Discharges (SMD) Plasma under Different Plasma Conditions at Different Humidities
J. Jeon, T. Klämpfl, J. L. Zimmermann, G. E. Morfill and T. Shimizu
New Journal of Physics 16, 103007 (2014)
Decontamination of Nosocomial Pathogens including Clostridium difficile Spores on Dry Inanimate Surface by Cold Atmospheric Plasma
G. Klämpfl, T. Shimizu, S. Koch, M. Balden, S. Gemein, Y.-F. Li, A. Mitra, J. L. Zimmermann, J. Gebel, G. E. Morfill and H.-U. Schmidt
Plasma Processes and Polymers 11, 10, 974-984 (2014)
Randomized placebo-controlled clinical trial showed cold atmospheric argon plasma relieved acute pain and accelerated healing in herpes zoster.
G. Isbary, T. Shimizu, J. L. Zimmermann, J. Heinlin, S. Al-Zaabi, M. Rechfeld, G. E. Morfill, S. Karrer and W. Stolz
Clinical Plasma Medicine Journal 2, 2, 50–55 (2014)
Cold atmospheric plasma – a new technology for spacecraft component decontamination
T. Shimizu, S. Barczyk, P. Rettberg, T. Shimizu, T. Klaempfl, J. L. Zimmermann, T. Hoeschen, C. Linsmeier, P. Weber, G. E. Morfill and H. M. Thomas
Planetary and Space Science 90, 60–71 (2014)
Bactericidal Agents Produced by Surface Micro-Discharge (SMD) Plasma by Controlling Gas Compositions
J. Jeon, T. M. Rosentreter, Y.-F. Li, G. Isbary, H. M. Thomas, J. L. Zimmermann, G. E. Morfill and T. Shimizu
Plasma Processes and Polymers 11, 5, 426-436 (2014)
Inactivation of surface borne microorganisms and increased germination of seed specimen by cold atmospheric plasma
A. Mitra, Y-F. Li, T. G. Klämpfl, T. Shimizu, J. Jeon, G. E. Morfill and J. L. Zimmermann
Food and Bioprocess Technology 7, 3, 645-653 (2014)
Cold atmospheric plasma for local infection control and subsequent pain reduction in a patient with chronic post-operative ear infection
G. Isbary, T. Shimizu, J. L. Zimmermann, G. E. Morfill and W. Stolz
New Microbes and New Infections 1, 3, 41-43 (2013)
Cold atmospheric plasma (CAP) changes gene expression of key molecules of the wound healing machinery and improves wound healing in vitro and in vivo
S. Arndt, P. Unger, E. Wacker, T. Shimizu, J. Heinlin, Y.-F. Li, H. M. Thomas, G. E. Morfill, J. L. Zimmermann, A.-K. Bosserhoff and S. Karrer
PLoS One 8, 11, e79325 (2013)
In vivo human skin treatment using two portable plasma devices: comparison of the bactericidal effects of a direct and an indirect cold atmospheric plasma treatment
Y.-F. Li, D. Taylor, J. L. Zimmermann, W. Bunk, R. Monetti, G. Isbary, V. Boxhammer, H.-U. Schmidt, T. Shimizu, H. M. Thomas and G. E. Morfill
Clinical Plasma Medicine Journal 1, 2, 35-39 (2013)
Contact-free inactivation of Trichophyton rubrum and Microsporum canis by cold atmospheric plasma treatment
J. Heinlin, T. Maisch, J. L. Zimmermann, T. Shimizu, T. Holzmann, M. Simon, J. Heidera, M. Landthaler, G. Morfill and S. Karrer
Future Microbiology 8, 9, 1097-1106 (2013)
Randomized placebo-controlled pilot study using cold atmospheric argon plasma on skin graft donor sites
J. Heinlin, J. L. Zimmermann, F. Zeman, W. Bunk, G. Isbary, M. Landthaler, T. Maisch, R. Monetti, G. E. Morfill, T. Shimizu, J. Steinbauer, W. Stolz and S. Karrer
Wound Repair and Regeneration 21, 6, 800-7 (2013)
Cold atmospheric argon plasma treatment accelerates wound healing in chronic wounds: results of a retrospective in vivo randomized controlled study
G. Isbary, W. Stolz, T. Shimizu, R. Monetti, G. Morfill, H.-U. Schmidt, W. Bunk, T. G. Klämpfl, B. Steffes, J. Heinlin, S. Karrer, M. Landthaler and J. L. Zimmermann
Clinical Plasma Medicine Journal 1, 2, 25-30 (2013)
Restoration of sensitivity in chemo-resistant glioma cells by cold atmospheric plasma
J. Köritzer, V. Boxhammer, A. Schäfer, T. Shimizu, T. G. Klämpfl, Y.-F. Li, C. Welz, S. Schwenk-Zieger, G. E. Morfill, J. L. Zimmermann and J. Schlegel
PLoS One 8, 5, e64498 (2013)
Cold atmospheric plasma, a new strategy to induce senescence in melanoma cells
S. Arndt, E. Wacker, S. Kaufmann, Y.-F. Li, T. Shimizu, H. M. Thomas, G. E. Morfill, S. Karrer, J. L.Zimmermann and A.-K. Bosserhoff
Experimental Dermatology 22, 4, 284-9 (2013)
Effects of cold atmospheric plasma on mucosal tissue culture
C. Welz, S. Becker, Y.-F. Li, T. Shimizu, J. Jeon, S. Schwenk-Zieger, H. M. Thomas, G. Isbary, G. E. Morfill, U. Harréus and J. L. Zimmermann
Journal of Physics D: Applied Physics 46, 045401 9pp (2013)
Investigation of the mutagenic potential of cold atmospheric plasma at bactericidal dosage
V. Boxhammer, Y.-F. Li, J. Köritzer, T. Shimizu, T. Maisch, G. E. Morfill, J. Schlegel and J. L. Zimmermann
Mutation Research 753, 23-28 (2013)
A randomized two-sided placebo-controlled study on the efficacy and safety of atmospheric non-thermal argon plasma for pruritus
J. Heinlin, G. Isbary, W. Stolz, F. Zeman, M. Landthaler, G. Morfill, T. Shimizu, J. L. Zimmermann and S. Karrer
Journal of the European Academy of Dermatology and Venereology 27, 3, 324-331 (2013)
Ex vivo human skin experiments for the evaluation of safety of new cold atmospheric plasma devices
G. Isbary, J. Koeritzer, A. Mitra, Y.-F. Li, T. Shimizu, J. Schroeder, W. Stolz, G. E. Morfill, J. Schegel and J. L. Zimmermann
Clinical Plasma Medicine Journal 1, 1, 36-44 (2013)
Cold atmospheric plasma devices for medical issues
G. Isbary, T. Shimizu, Y.-F. Li, W. Stolz, H. M. Thomas, G. E. Morfill and J. L. Zimmermann
Expert Review of Medical Devices 10, 3, 367-377 (2013)
Non-thermal plasma and evidence based medicine – more than five years of clinical experience
G. Isbary, J. L. Zimmermann, T. Shimizu, Y.-F. Li, G. E. Morfill, H. M. Thomas, B. Steffes, J. Heinlin, S. Karrer and W. Stolz
Clinical Plasma Medicine Journal 1, 1, 19-23 (2013)
Bactericidal action of cold atmospheric plasma in solution
V. Boxhammer, G. E. Morfill, J. R. Jokipii, T. Shimizu, T. Klämpfl, Y.-F. Li, J. Köritzer, J. Schlegel and J. L. Zimmermann
New Journal of Physics 14, 113042 (2012)
The dynamics of ozone generation and mode transition in air surface micro-discharge plasma at atmospheric pressure
T. Shimizu, Y. Sakiyama, D. B. Graves, J. L. Zimmermann and G. E. Morfill
New Journal of Physics 14, 103028 (2012)
Guiding of reactive plasma species by micro-channels
Y.-F. Li, J. L. Zimmermann, T. Klämpfl and G. E. Morfill
Plasma Processes and Polymers 9, 10, 1001-1005 (2012)
Test for bacterial resistance build-up against plasma treatment
J. L. Zimmermann, T. Shimizu, H.-U. Schmidt, Y.-F. Li, G. E. Morfill and G. Isbary
New Journal of Physics 14, 073037 (2012)
Disinfection through different textiles using low-temperature atmosphere pressure plasma
J. L. Zimmermann, T. Shimizu, V. Boxhammer and G. E. Morfill
Plasma Processes and Polymers 9, 8, 792-798 (2012)
Contact-free cold atmospheric plasma treatment of Deinococcus radiodurans
T. Maisch, T. Shimizu, A. Mitra, J. Heinlin, S. Karrer, Y.-F. Li, G. E. Morfill and J. L. Zimmermann
Journal of Industrial Microbiology & Biotechnology 39, 9, 1367-75 (2012)
Atmospheric air plasma – sterilization against spores and other microorganisms of clinical interest
T. Klämpfl, G. Isbary, T. Shimizu, J. L. Zimmermann, Y.-F. Li, W. Stolz, J. Schlegel, G. E. Morfill and H.-U. Schmidt
Applied Environ Microbiology 78, 15, 5077-82 (2012)
Contact-free inactivation of Candida albicans biofilm by cold atmospheric air plasma
T. Maisch, T. Shimizu, G. Isbary, J. Heinlin, S. Karrer, Y.-F. Li, G. Morfill and J. L. Zimmermann
Applied and Environmental Microbiology 78, 12, 4242-7 (2012)
Decolonisation of MRSA, S. aureus and E. coli by cold-atmospheric plasma using a porcine skin model in vitro
T. Maisch, T. Shimizu, Y.-F. Li, J. Heinlin, S. Karrer, G. Morfill and J. L. Zimmermann
PLoS One 7, 4, 34610 (2012)
Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial
G. Isbary, J. Heinlin, T. Shimizu, J. L. Zimmermann, G. Morfill, H.-U. Schmidt, R. Monetti, B. Steffes, W. Bunk, Y. Li, T. Klaempfl, S. Karrer, M. Landthaler and W. Stolz
British Journal of Dermatology 167, 404-410 (2012)
Optimizing the distance for bacterial treatment using surface micro-discharge plasma
Y.-F. Li, J. L. Zimmermann and G. E. Morfill
New Journal of Physics 14, 023058 (2012)
Cold atmospheric plasma for surface disinfection
Y.-F. Li, T. Shimizu, J. L. Zimmermann and G. E. Morfill
Plasma Processes and Polymers 9, 585-589 (2012)
Reasons why we need cold atmospheric plasmas in bacteria related diseases in medicine
G. Isbary, J. L. Zimmermann, T. Shimizu, G. E. Morfill, A. Mitra, H. M. Thomas, T. G. Klämpfl, J. Koeritzer, V. Boxhammer, J. Schlegel and W. Stolz
Plasma Medicine 2, 1-3, 85-96 (2012)
Cold atmospheric plasma for skin treatment
T. Shimizu, J. L. Zimmermann, G. E. Morfill, G. Isbary and W. Stolz
Journal of the Japan Society of Mechanical Engineers 115, 488 (2012)
Plasma Health Care – old problems, new solutions
G. E. Morfill and J. L. Zimmermann
Contributions to Plasma Physics 52, 7, 655-663 (2012)
Applications in plasma medicine – a SWOT approach
A. Mitra, G. E. Morfill, T. Shimizu, B. Steffes, G. Isbary, H.-U. Schmidt, Y.-F. Li and J. L. Zimmermann
Composite Interfaces 19, 3-4, 231-238 (2012)
Kalte atmosphärische Plasmen – eine innovative Technologie zur Behandlung resistenter Pathogene und für Wundheilungszwecke
G. Isbary, J. Zimmermann, T. Shimizu, G. Morfill, Y. Li, H.-U. Schmidt, J. Heinlin, S. Karrer, M. Landthaler, B. Steffes, W. Bunk, R. Monetti and W. Stolz
Zeitschrift für Wundheilung (Suppl A) 41-46 (2012)
Effects of cold atmospheric plasmas on adenoviruses in solution
J. L. Zimmermann, K. Dumler, T. Shimizu, G. E. Morfill, A. Wolf, V. Boxhammer, J. Schlegel, B. Gansbacher and M. Anton
Journal of Physics D: Applied Physics 44, 505201 (2011)
The bactericidal effect of surface micro-discharge plasma under different ambient conditions
T. Shimizu, J. L. Zimmermann and G. E. Morfill
New Journal of Physics 13, 023026 7pp (2011)
Cold atmospheric plasma: A successful treatment of lesions in Hailey-Hailey disease
G. Isbary, G. Morfill, J. Zimmermann, T. Shimizu and W. Stolz
Archives of Dermatology 147, 4, 388-390 (2011)
Transport Mechanism of Chemical Species in a Pin-water Atmospheric Discharge driven by Negative Voltage
T. Shimizu, Y. Iwafuchi, G. E. Morfill and T. Sato
Journal of Photopolymer Science and Technology 24, 421 (2011)
Formation of thermal flow fields and chemical transport in air and water by atmospheric plasma
T. Shimizu, Y. Iwafuchi, G. E. Morfill and T. Sato
New Journal of Physics 13, 053025 (2011)
Bactericidal effects of non-thermal argon plasma in vitro, in biofilms and in the animal model of infected wounds
A. Ermolaeva, A. F. Varfolomeev, M. Yu. Chernukha, D. S. Yurov, M. M. Vasiliev, A. A. Kaminskaya, M. M. Moisenovich, J. M. Romanova, A. N. Murashev, I. I. Selezneva, T. Shimizu, E. V. Sysolyatina, I. A. Shaginyan, O. F. Petrov, E. I. Mayevsky, V. E. Fortov, G. E. Morfill, B. S. Naroditsky and A. L. Gintsburg
Journal of Medical Microbiology 60, 75-83 (2011)
Plasma applications in medicine with a special focus on dermatology
J. Heinlin, G. Isbary, W. Stolz, G. E. Morfill, M. Landthaler, T. Shimizu, B. Steffes, T. Nosenko, J. L. Zimmermann and S. Karrer
Journal of the European Academy of Dermatology and Venereology 25, 1, 1-11 (2011)
A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients
G. Isbary, G. E. Morfill, H.-U. Schmidt, M. Georgi, K. Ramrath, J. Heinlin, S. Karrer, M. Landthaler, T. Shimizu, B. Steffes, W. Bunk, R. Monetti, J. L. Zimmermann, R. Pompl and W. Stolz
British Journal of Dermatology 163, 1, 78-82 (2010)
Characterization of Low-Temperature Microwave Plasma Treatment with and without UV Light for Disinfection
T. Shimizu, T. Nosenko, G. E. Morfill, T. Sato, H.-U. Schmidt and T. Urayama
Plasma Processes and Polymers 7, 288-293 (2010)
Plasma wound treatment
G. E. Morfill, G. Isbary, S. Karrer and J. Zimmermann
Next Med Conference Newport Beach (2010)
Plasma medicine: possible applications in dermatology
J. Heinlin, G. E. Morfill, M. Landthaler, W. Stolz, G. Isbary, J. L. Zimmermann, T. Shimizu and S. Karrer
Journal der Deutschen Dermatologischen Gesellschaft 8, 12, 968-976 (2010)
The effect of low-temperature plasma on bacteria as observed by repeated AFM imaging
R. Pompl, F. Jamitzky, T. Shimizu, B. Steffes, W. Bunk, H.-U. Schmidt, M. Georgi, K. Ramrath, W. Stolz, R. W. Stark, T. Urayama, S. Fujii and G. E. Morfill
New Journal of Physics 11, 115023 11pp (2009)
Nosocomial infections – a new approach towards preventive medicine using plasmas
G. E. Morfill, T. Shimizu, B. Steffes and H.-U. Schmidt
New Journal of Physics 11, 115019 10pp (2009)
Designing plasmas for chronic wound disinfection
T. Nosenko, T. Shimizu and G. E. Morfill
New Journal of Physics 11, 115013 19pp (2009)
Plasma medicine: an introductory review
M. G. Kong, G. Kroesen, G. E. Morfill, T. Nosenko, T. Shimizu, J. van Dijk and J. L. Zimmermann
New Journal Physics 11, 115012 35pp (2009)
Focus on plasma medicine
G. E. Morfill, M. G. Kong and J. L. Zimmermann
New Journal of Physics 11, 115011 8pp (2009)
Characterization of Microwave Plasma Torch for Decontamination
T. Shimizu, B. Steffes, R. Pompl, F. Jamitzky, W. Bunk, K. Ramrath, M. Georgi, W. Stolz, H.-U. Schmidt, T. Urayama, S. Fujii and G. E. Morfill
Plasma Process. Polym. 5, 577-582 (2008)
in the media
Cold Plasmas: Hospital-Clean Hands, Without All the Scrubbing
Plasma, der Bakterienkiller
Heilsames Plasma:
Kalte Plasmen eröffnen neue Wege in der medizinischen Therapie
Kaltes Plasma tötet multiresistente Keime, verbessert die Wundheilung und lässt Pflanzen schneller keimen.
Medizin: Kaltes Plasma gegen Gifte und Keime
heute journal: Sternenforscher besiegt Keime
If not directly linked to the respective media logo, the articles can be made available for viewing on request.